Embedded Files
COMPARISON BETWEEN INTRAOPERATIVE FEATURES OF MORBIDLY ADHERENT PLACENTA WITH PRENATAL ULTRASONIC FEATURES
COMPARISON BETWEEN INTRAOPERATIVE FEATURES OF MORBIDLY ADHERENT PLACENTA WITH PRENATAL ULTRASONIC FEATURES
Juanita Salah Ahmed a, Ariana Khalis Jawad b, and Huda Muhaddien Muhammad c
Juanita Salah Ahmed a, Ariana Khalis Jawad b, and Huda Muhaddien Muhammad c
a KBMS Candidate, Obstetrics & Gynecology, Sulaimania Maternity Hospital, Kurdistan Region /Iraq.
b Department of Obstetrics & Gynecology, College of Medicine, Erbil Medical University, Kurdistan Region /Iraq.
c Department of Obstetrics and Gynecology, College of Medicine University of Sulaimani, Kurdistan Region /Iraq.
Submitted: 7/6/2019; Accepted: 17/2/2020; Published: 21/3/2020
DOI Link: https://doi.org/10.17656/jsmc.10240
ABSTRACT
Background
The term morbidly adherent placenta characterized by abnormally implanted, invasive, or adhered placenta, which is increasing in obstetrical practice mainly due to increasing rate of cesarean section associated with increasing mortality and morbidity which can be avoidable by good assessment by ultrasound before operation.
Objectives
The aim of this study was to assess the diagnostic accuracy of pre-natal ultrasound in detecting morbidly adherent placenta in patients at risk.
Materials and Methods
Prospective observational study, case sheets of 125 women reviewed having placenta previa and previous uterine surgery (CS, myomectomy or curettage) from May 2018 to May 2019, population included 38 pregnant women. All cases of complete placenta previa or low-lying placenta, scans performed through either trans abdominal ultrasonography or transvaginal ultrasonography in their second and third trimesters of pregnancy, signs were loss of clear zone, placental lacunae, myometrial thinning, placental bulge, focal exophytic mass, and bladder wall interruption with the availability of more than three finding regarded as highly suspicious and final diagnosis made during cesarean section.
Results
Among 38 patients with risks, there was a significant correlation between increasing age and extend of morbidly adherent placenta. The average gestational age of the patients was 36.2 weeks, ranging from 20-39.3 weeks. All cases at least underwent prior caesarean delivery. There was increasing incidence of MAP with increasing number in C/S. In women with risk of MAP along with highly suspicious ultrasound findings, fourteen cases underwent hysterectomy, uterus-sparing alternatives to manage this condition can be an option in selected cases, the most reliable signs for suspecting percreta were placental bulge, focal exophytic mass, and bladder wall interruption, the sensitivity and positive predictive value was 70% and 90% respectively.
Conclusion
Management with prediction of MAP by ultrasonography is useful for obtaining permissible morbidity.
KEYWORDS
Morbidly adherent placenta (MAP), Placenta accreta, increta, percreta, Ultrasound imaging, Prenatal diagnosis, Cesarean section (C/S).
References
1. Benirschke K, Burton GJ, Baergen RN. Pathology of the human placenta. 6th ed. Berlin: Springer Verlag; 2012.
2. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006; 107(4):927-41.
3. Publications Committee SfM-FM, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010; 203(5):430-9.
4. Cunningham FG, Leveno KJ, Bloom SL. Obstetrical Hemorrhage. 25th ed. New York, NY: McGraw-Hill Education; 2018.
5. Duzyj CM, Barishansky S, Khan S, et al: Evidence of active wound remodeling at the site of trophoblast invasion in placenta accreta. Abstract No. 1 47, Am Obstet Gynecol 2 1 6:S99, 2017
6. Wehrum M , Buhimschi lA, Salaia C , e t al: Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am Obstet Gynecol 204(5):4 1 1 .e l, 20 11
7. Pri-Paz S, Devine PC, Miller RS, et al: Cesarean hysterectomy requiring emergent thoracotomy: a case report of a complication of placenta percreta requiring a multidisciplinary efort. J Reprod Med 57(1 -2):58, 20 12
8. Linn RL, Miller ES, Lim G, et al: Adherent basal plate myometrial fibers in the delivered placenta as a risk factor for development of subsequent placenta accreta. Placenta 36( 1 2):1419, 20 15
9. Miller ES, Linn L, Ernst LM: Does the presence of placental basal plate myometrial ibers in a prior pregnancy improve prediction of placenta accreta? B OG 1 23(13):2 1 40, 2016
10. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218(1):75-87.
11. Happe SK, Rac MW, Moschos E, et al: Prospective assessment of morbidly adherent placenta with irst trimester ultrasound. Presented at the 38th Annual Meeting of the Society for Maternal-Fetal Medicine, January 29- February 3, 20 18
12. Silver RM. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 2015; 126(3):654-68.
13. Klar M, Michels KB. Cesarean section and placental disorders in subsequent pregnancies--a meta-analysis. J Perinat Med. 2014; 42(5):571-83.
14. Gyamfi-Bannerman C, Gilbert S, Landon MB, Spong CY, Rouse DJ, Varner MW, et al. Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol. 2012; 120(6):1332-7.
15. Gill LA, Baldwin E, Lessard-Anderson C, White W. Septic abortion with placenta accreta in pregnancy after endometrial ablation. Obstet Gynecol. 2015; 125(4):822-4.
16. Rac MW, Mcintire DO, Wells CE, et al: Cervical length in patients at risk for placental accreta. Ultrasound Med 36( ):1431, 2017
17. Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016; 215(6):712-21.
18. Tam Tam KB, Dozier J, Martin JN, Jr. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med. 2012; 25(4):329-34.
19. Collins SL, Ashcroft A, Braun T, et al. Proposed for standardized ultrasound descriptions of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 2016;47:271-5.
20. Wong HS, Cheung YK, Zuccollo J, Tait J, Pringle KC. Evaluation of sonographic diagnostic criteria for placenta accreta. J Clin Ultrasound. 2008; 36(9):551-9.
21. Rac MW, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015; 212(3):343.
22. Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accrete in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004; 190:1135-40.
23. Japaraj RP, Mimin TS, Mukudan K. Antenatal diagnosis of placenta previa accreta in patients with previous cesarean scar. J Obstet Gynaecol Res. 2007; 33(4):431-7.
24. Moodley J, Ngambu NF, Corr P. Imaging techniques to identify morbidly adherent placenta praevia: a prospective study. J Obstet Gynaecol. 2004; 24(7):742-4.
25. ShihJC,PalaciosJaraquemadaJM,SuYN, etal.Roleofthree-dimensionalpowerDopplerin the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009;33:193-203.
26. Matsuo K, Conturie CL, Lee RH. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol. 2014; 181:341-2.
27. Palacios-Jaraquemada JM, Bruno CH, Martin E. MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand. 2013; 92(4):392-7.
28. Zhang J, Li H, Wang F, Qin H, Qin Q. Prenatal Diagnosis of Abnormal Invasive Placenta by Ultrasound: Measurement of Highest Peak Systolic Velocity of Subplacental Blood Flow. Ultrasound Med Biol. 2018; 44(8):1672-8.
29. Rac MW, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015;212:343.e1-7
30. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006; 107(6):1226-32.
31. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011; 90(10):1140-6.
32. D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013; 42(5):509-17.
33. Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013; 92(4):439-44.
34. Guleria K, Gupta B, Agarwal S, Suneja A, Vaid N, Jain S. Abnormally invasive placenta: changing trends in diagnosis and management. Acta Obstet Gynecol Scand. 2013; 92(4):461-4.
35. Maged AM, Abdelaal H, Salah E, Saad H, Meshaal H, Eldaly A, et al. Prevalence and diagnostic accuracy of Doppler ultrasound of placenta accreta in Egypt. J Matern Fetal Neonatal Med. 2018; 31(7):933-9.
36. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015; 212(2):218.
© The Authors, published by University of Sulaimani, College of Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Page updated
Report abuse